BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yeung DT, Bough KJ, Harper JR, Platoff GE Jr. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019. J Med Toxicol 2020;16:87-105. [PMID: 31853736 DOI: 10.1007/s13181-019-00750-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Algera MH, Cotten JF, van Velzen M, Niesters M, Boon M, Shoham DS, Dandrea KE, van der Schrier R, Dahan A. Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression? Pharmacol Res Perspect 2022;10:e00974. [PMID: 35621218 DOI: 10.1002/prp2.974] [Reference Citation Analysis]
2 Zhang T, Li M, Han X, Nie G, Zheng A. Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride. AAPS PharmSciTech 2022;23:143. [PMID: 35578146 DOI: 10.1208/s12249-022-02252-6] [Reference Citation Analysis]
3 van der Schrier R, Dahan JDC, Boon M, Sarton E, van Velzen M, Niesters M, Dahan A. Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity. Anesthesiology 2021. [PMID: 34958670 DOI: 10.1097/ALN.0000000000004096] [Reference Citation Analysis]
4 Valdez CA, Leif RN, Sanner RD, Corzett TH, Dreyer ML, Mason KE. Structural modification of fentanyls for their retrospective identification by gas chromatographic analysis using chloroformate chemistry. Sci Rep 2021;11:22489. [PMID: 34795347 DOI: 10.1038/s41598-021-01896-x] [Reference Citation Analysis]
5 Valdez CA. Gas Chromatography-Mass Spectrometry Analysis of Synthetic Opioids Belonging to the Fentanyl Class: A Review. Crit Rev Anal Chem 2021;:1-31. [PMID: 34053394 DOI: 10.1080/10408347.2021.1927668] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dandrea KE, Cotten JF. A Comparison of Breathing Stimulants for Reversal of Synthetic Opioid-Induced Respiratory Depression in Conscious Rats. J Pharmacol Exp Ther 2021;378:146-56. [PMID: 34021024 DOI: 10.1124/jpet.121.000675] [Reference Citation Analysis]
7 France CP, Ahern GP, Averick S, Disney A, Enright HA, Esmaeli-Azad B, Federico A, Gerak LR, Husbands SM, Kolber B, Lau EY, Lao V, Maguire DR, Malfatti MA, Martinez G, Mayer BP, Pravetoni M, Sahibzada N, Skolnick P, Snyder EY, Tomycz N, Valdez CA, Zapf J. Countermeasures for Preventing and Treating Opioid Overdose. Clin Pharmacol Ther 2021;109:578-90. [PMID: 33113208 DOI: 10.1002/cpt.2098] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
8 Throckmorton DC, Volkow N, Platoff G, Amaya K, Laney J. Multi-Agency Development of Medical Countermeasures Against Opioid-Induced Respiratory Depression. Clin Pharmacol Ther 2021;109:576-7. [PMID: 33170949 DOI: 10.1002/cpt.2070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Yeung DT, Araj H, Harper JR, Platoff GE Jr. Considerations in developing medical countermeasures against chemical ocular toxicity. Toxicol Lett 2020;334:1-3. [PMID: 32916183 DOI: 10.1016/j.toxlet.2020.09.004] [Reference Citation Analysis]
10 Yeung DT, Harper JR, Platoff GE Jr. The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people. Drug Dev Res 2020. [PMID: 32573018 DOI: 10.1002/ddr.21707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]